BAA contract titled, "consortium for TB biomarkers biorepository."
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201510094C
- Awardee
-
The Global Alliance For TB Drug Development Inc. UEI CA1RNRESAZU6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $200,000
Award facts
- Opportunity
-
- FDABAA1500121 Solicitation number
- Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science Award Notice · Posted Feb 23, 2015
- Contract value 100% obligated
- $200,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10005, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $200,000 |
About this award
The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price contract worth $200,000.00 to The Global Alliance For TB Drug Development Inc. (TB Alliance) for a project titled "Consortium for TB Biomarkers Biorepository." The award has an ultimate completion date of February 28, 2018. TB Alliance is a non-profit organization focused on accelerating the development of new tuberculosis (TB) drugs and treatment regimens. This contract supports the organization's research and development efforts to address significant public health challenges related to TB, including drug-resistant strains, for both civilian and military populations. The award does not have a set-aside designation.
Quick answers
Who was awarded contract HHSF223201510094C?
HHSF223201510094C was awarded to The Global Alliance For TB Drug Development Inc. by Food and Drug Administration (Department of Health and Human Services) on August 26, 2015.
How much is contract HHSF223201510094C worth?
The government has obligated $200,000 on HHSF223201510094C.
Was contract HHSF223201510094C competed?
The extent of competition for HHSF223201510094C was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award